Author: racetab

Non-selective Adenosine

Although early studies suggested that and status could predict response to EGFR-targeted therapies [201, 202], outcome was not correlated with the presence of amplification, loss or other molecular alterations in subsequent studies, and molecular predictors for the efficacy of EGFR targeted therapies remain undetermined

Although early studies suggested that and status could predict response to EGFR-targeted therapies [201, 202], outcome was not correlated with the presence of amplification, loss

View More